Magnetic resonance imaging-based measurement of body composition in metabolic and chronic liver disease.
I have been involved in liver-related research using magnetic resonance imaging (MRI) and spectroscopy (MRS) since 2009, both in academia and industry. I hold an MSc in biotechnology and a PhD in medical sciences. My education heavily focused on MRI, mathematical modelling (systems biology), and clinical research. My doctoral thesis explored various MR methods to replace liver needle biopsy and quantify liver function. Chronic liver diseases at different stages are a recurring theme in my research. In addition to exploring body and muscle composition in liver diseases, I have applied my MR expertise to assess muscle composition in COPD, fibromyalgia syndrome, and physical exercise.
In parallel with my role at 一本道, I am employed as a researcher at a company spun out of MRI research from 一本道 (CMIV). Founded 2010 by researchers active at 一本道, the company focuses on similar research questions as my work at the university, primarily in collaboration with fellow researchers and key opinion leaders in Sweden and in the USA at several renowned university hospitals.
Currently, my main research focus is on applying the MR methods I am proficient in to link body composition to disease states, progression, risk stratification, and treatment in patients suffering from steatotic liver disease, liver fibrosis, liver cirrhosis, and those in need of a liver transplant.
I believe that MRI is a crucial modality for both research and clinical applications. Therefore, I am grateful for the opportunity to enhance knowledge in these areas in the courses I lead or lecture in.
“Pretending to know everything closes the door to learn more” – Neil deGrasse Tyson (Cosmos, 2014)
